1. Home
  2. CTOR vs ANVS Comparison

CTOR vs ANVS Comparison

Compare CTOR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • ANVS
  • Stock Information
  • Founded
  • CTOR 2021
  • ANVS 2008
  • Country
  • CTOR United States
  • ANVS United States
  • Employees
  • CTOR N/A
  • ANVS N/A
  • Industry
  • CTOR
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTOR
  • ANVS Health Care
  • Exchange
  • CTOR NYSE
  • ANVS Nasdaq
  • Market Cap
  • CTOR 89.9M
  • ANVS 92.6M
  • IPO Year
  • CTOR N/A
  • ANVS 2020
  • Fundamental
  • Price
  • CTOR $1.23
  • ANVS $2.58
  • Analyst Decision
  • CTOR Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • CTOR 2
  • ANVS 6
  • Target Price
  • CTOR $4.50
  • ANVS $31.40
  • AVG Volume (30 Days)
  • CTOR 78.9K
  • ANVS 599.3K
  • Earning Date
  • CTOR 02-21-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • CTOR N/A
  • ANVS N/A
  • EPS Growth
  • CTOR N/A
  • ANVS N/A
  • EPS
  • CTOR N/A
  • ANVS N/A
  • Revenue
  • CTOR N/A
  • ANVS N/A
  • Revenue This Year
  • CTOR N/A
  • ANVS N/A
  • Revenue Next Year
  • CTOR N/A
  • ANVS N/A
  • P/E Ratio
  • CTOR N/A
  • ANVS N/A
  • Revenue Growth
  • CTOR N/A
  • ANVS N/A
  • 52 Week Low
  • CTOR $0.85
  • ANVS $2.44
  • 52 Week High
  • CTOR $49.00
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • ANVS 18.79
  • Support Level
  • CTOR N/A
  • ANVS $2.44
  • Resistance Level
  • CTOR N/A
  • ANVS $5.50
  • Average True Range (ATR)
  • CTOR 0.00
  • ANVS 0.32
  • MACD
  • CTOR 0.00
  • ANVS -0.17
  • Stochastic Oscillator
  • CTOR 0.00
  • ANVS 5.22

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: